Literature DB >> 25302681

Thrombosis: a major contributor to global disease burden.

Gary E Raskob1, Pantep Angchaisuksiri2, Alicia N Blanco3, Harry Büller4, Alexander Gallus5, Beverley J Hunt6, Elaine M Hylek7, The Lord Kakkar8, Stavros V Konstantinides9, Micah McCumber1, Yukio Ozaki10, Aaron Wendelboe1, Jeffrey I Weitz11.   

Abstract

Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden due to VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted-life-years (DALYs) lost in low- and middle-income countries, and second in high-income countries, responsible for more DALYs lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low-, middle-, and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate if improved utilization of preventive measures will reduce the burden. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Year:  2014        PMID: 25302681     DOI: 10.1055/s-0034-1390325

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  39 in total

1.  Association between PON1 L55M polymorphism and ischemic stroke: a systematic review and meta-analysis.

Authors:  Peng Shao; Da-Jun Qu; Rui-Ying Song; Ming-Lu Chen; Li-Hua Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  More or less living according to your blood type.

Authors:  Leonardo Pasalic; Emmanuel J Favaloro
Journal:  Blood Transfus       Date:  2014-12-17       Impact factor: 3.443

3.  Novel Mouse Model for Studying Hemostatic Function of Human Platelets.

Authors:  David S Paul; Wolfgang Bergmeier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-06-04       Impact factor: 8.311

Review 4.  Medicinal plants with antithrombotic property in Persian medicine: a mechanistic review.

Authors:  Zahra Memariani; Reihaneh Moeini; Shokooh Sadat Hamedi; Narjes Gorji; Seyyed Ali Mozaffarpur
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

5.  Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.

Authors:  Magnus S Edvardsen; Kristian Hindberg; Ellen-Sofie Hansen; Vânia M Morelli; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; Line H Evensen; John-Bjarne Hansen
Journal:  Blood Adv       Date:  2021-01-12

Review 6.  Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism.

Authors:  Meredith Turetz; Andrew T Sideris; Oren A Friedman; Nidhi Triphathi; James M Horowitz
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

7.  Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.

Authors:  Manu Thomas Kalathottukaren; Libin Abraham; Piyushkumar R Kapopara; Benjamin F L Lai; Rajesh A Shenoi; Federico I Rosell; Edward M Conway; Edward L G Pryzdial; James H Morrissey; Charles A Haynes; Jayachandran N Kizhakkedathu
Journal:  Blood       Date:  2016-12-29       Impact factor: 22.113

8.  Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I.

Authors:  Ramya Billur; David Ban; T Michael Sabo; Muriel C Maurer
Journal:  Biochemistry       Date:  2017-11-21       Impact factor: 3.162

9.  Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.

Authors:  Lihu Gong; Min Liu; Tu Zeng; Xiaoli Shi; Cai Yuan; Peter A Andreasen; Mingdong Huang
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

10.  Structural Basis for Activity and Specificity of an Anticoagulant Anti-FXIa Monoclonal Antibody and a Reversal Agent.

Authors:  Lauren K Ely; Marco Lolicato; Tovo David; Kate Lowe; Yun Cheol Kim; Dharmaraj Samuel; Paul Bessette; Jorge L Garcia; Thomas Mikita; Daniel L Minor; Shaun R Coughlin
Journal:  Structure       Date:  2018-01-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.